Virios therapeutics llc

Major-Pharmaceuticals

VIRI


Executive/
Director

Price

  • Last Close
  • $ 0.18
    $ +0.01 7.06 %
    Aug 29, 2024
  • 52-Week High/Low
  • $1.13 - $0.17
  • YTD
  • -68.3%

  • Trading Volume
  • 2,064
  • Market Cap Full
  • $ 3.5M
  • Shares Outstanding
  • 19.3M
    Nov 9, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% -23.4% -12.4% 55.9% -16.7%
Q2 - - - - - 4% 9.3% -5.6% 275% -6.9%
Q3 - - - - - 8% -15.9% -91% -33% -
Q4 - - - - - -55.1% -3.3% -38.1% -36.1% -
J F M A M J J A S O N D
2024 -28.7% -9.5% 29.1% 12.7% - - - - - - - -
2023 30.9% -2.9% 22.7% 98.4% 135.6% -19.8% 37.7% -42.1% -15.9% -40.5% 3.5% 1.1%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%-32%-95%144%-68%

Earnings

2020 2021 2022 2023
Q1 - -0.37 -0.48 -0.08
Q2 - -0.51 -0.44 -0.08
Q3 - -0.49 -0.28 -0.06
Q4 - -0.55 0.09 -
A -2.1 -1.9 -1.1 -0.22

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 8.3 18.3
Jun 8.3 8.3 18.3
Sep 8.3 8.3 -
Dec 8.3 18.3 19.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage - - - - -
Equity multiplier - - - - -